Ipsogen appoints VP of business on eve of US expansion
This article was originally published in Clinica
Susan Hertzberg has been appointed vice-president of corporate business at Ipsogen (Marseille, France) and president of its US subsidiary based in New Haven, Connecticut. The firm specialises in developing molecular diagnostic assays for breast cancer and leukaemia. She joins the firm as it plans to expand its business in both the North American market and globally. Ms Hertzberg joins from Abbott Diagnostics, where she was general manager of global accounts. And she spent much of her career at Quest Diagnostics, including as vice-president of purchasing and materials management, and as vice-president of marketing. Her commercial expertise and knowledge of the IVD and laboratory sectors will be a “great advantage”, said the firm’s CEO Vincent Fert.